- Home
- AMG vs CORT Comparison
AMG vs CORT Comparison
Compare AMG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMG
- CORT
- Stock Information
- Founded
- AMG 1993
- CORT 1998
- Country
- AMG United States
- CORT United States
- Employees
- AMG N/A
- CORT N/A
- Industry
- AMG Investment Managers
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AMG Finance
- CORT Health Care
- Exchange
- AMG Nasdaq
- CORT Nasdaq
- Market Cap
- AMG 5.6B
- CORT 5.6B
- IPO Year
- AMG 1997
- CORT N/A
- Fundamental
- Price
- AMG $188.68
- CORT $61.11
- Analyst Decision
- AMG Buy
- CORT Strong Buy
- Analyst Count
- AMG 5
- CORT 4
- Target Price
- AMG $202.40
- CORT $75.25
- AVG Volume (30 Days)
- AMG 222.6K
- CORT 773.5K
- Earning Date
- AMG 02-03-2025
- CORT 02-13-2025
- Dividend Yield
- AMG 0.02%
- CORT N/A
- EPS Growth
- AMG N/A
- CORT 57.97
- EPS
- AMG 15.64
- CORT 1.26
- Revenue
- AMG $2,019,200,000.00
- CORT $628,555,000.00
- Revenue This Year
- AMG $0.54
- CORT $46.29
- Revenue Next Year
- AMG $4.83
- CORT $17.09
- P/E Ratio
- AMG $12.03
- CORT $48.47
- Revenue Growth
- AMG N/A
- CORT 39.67
- 52 Week Low
- AMG $147.13
- CORT $20.84
- 52 Week High
- AMG $199.52
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- AMG 56.58
- CORT 70.63
- Support Level
- AMG $173.64
- CORT $49.00
- Resistance Level
- AMG $187.47
- CORT $52.17
- Average True Range (ATR)
- AMG 3.47
- CORT 2.04
- MACD
- AMG 0.60
- CORT 0.97
- Stochastic Oscillator
- AMG 96.41
- CORT 98.94
About AMG Affiliated Managers Group Inc.
Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to midsize boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of December 2023, AMG's affiliate network—which includes firms like AQR Capital Management, and Pantheon in alternative assets and other products (which accounted for 35% of AUM), Artemis, Genesis, Harding Loevner, and Tweedy Browne in global and emerging-market equities (28%) and Frontier, River Road, Parnassus, and Yacktman in U.S. equities (21%)—had $672.2 billion in managed assets.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.